Tuesday, 17 November 2026European Markets

INVENTIVA Stock Falls By 28% In The Last 21 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - shares of inventiva (cac 40: iva.pa) dropped by a staggering 28.57% in 21 sessions from €5.11 to €3.65 at 14:08 est on thursday, after three consecutive sessions in a row of losses. cac 40 is dropping 0.28% to €7,110.96, after three consecutive sessions in a row of gains.

about inventiva

inventiva s.a., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (nash), mucopolysaccharidoses (mps), and other diseases. its lead product candidate is lanifibranor, which has completed phase iib clinical trial to treat nash. the company also develops odiparcil, which has completed phase iia clinical trial for the treatment of mps vi subtype disease. in addition, it has a pipeline of earlier stage programs in oncology and other diseases. the company has strategic collaboration with abbvie for the treatment of autoimmune diseases; and boehringer ingelheim international gmbh for developing new treatments for idiopathic pulmonary fibrosis. inventiva s.a. was founded in 2011 and is based in daix, france.

earnings per share

as for profitability, inventiva has a trailing twelve months eps of €-0.992.

volume

today's last reported volume for inventiva is 7184 which is 87.11% below its average volume of 22662.

more news about inventiva (iva.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 23 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›

In this story · Knowledge Files